Showing 1 - 10 of 14
Persistent link: https://www.econbiz.de/10001808638
Persistent link: https://www.econbiz.de/10001673856
"Efforts to strengthen the global patent system for pharmaceuticals continue to be controversial, and what will likely be a similarly fraught international debate over price controls has begun. The outcome of international negotiations and the resulting policy decisions made by each country will...
Persistent link: https://www.econbiz.de/10002822126
Persistent link: https://www.econbiz.de/10001448427
Persistent link: https://www.econbiz.de/10000913202
Persistent link: https://www.econbiz.de/10001637684
Since the late 1980s the global intellectual property rights (IPR) system has been strengthening dramatically as much of the developing world introduces patent protection for new drug products. This may lead to more research on drugs to address developing country needs. As there are identifiable...
Persistent link: https://www.econbiz.de/10013222046
Since the late 1980s the global intellectual property rights (IPR) system has been strengthening dramatically as much of the developing world introduces patent protection for new drug products. This may lead to more research on drugs to address developing country needs. As there are identifiable...
Persistent link: https://www.econbiz.de/10012471281
The protection of pharmaceutical innovations is being dramatically extended as much of the developing world introduces patent protection for new drug products. This change in intellectual property rights may lead to more research on drugs to address developing country needs. The authors use...
Persistent link: https://www.econbiz.de/10015120304
There continues to be widespread criticism of the extension of patent rights on pharmaceuticals in the developing world as required by World Trade Organization membership. This paper examines arguments in favor and against this strengthening of worldwide patent protection. It emphasizes that...
Persistent link: https://www.econbiz.de/10014048997